Literature DB >> 19632058

Inhalant withdrawal as a clinically significant feature of inhalant dependence disorder.

Brian E Perron1, Matthew O Howard, Michael G Vaughn, Christopher N Jarman.   

Abstract

Inhalant use is the intentional inhalation of vapors from commercial products or specific chemical agents for the purpose of achieving intoxication. Inhalants are among the most common and pernicious forms of substance use and the least studied of the major drugs. Diagnosis of inhalant dependence, according to the DSM-IV [Weintraub E, Gandhi D, Robinson C. Medical complications due to mothball abuse. South Med J 2000;93:427-9] excludes inhalant withdrawal symptoms, as expert opinion has suggested that an inhalant withdrawal syndrome is neither common nor clinically significant. This article draws from multiple sources of data to suggest that withdrawal symptoms can be part of inhalant dependence and are clinically significant. This hypothesis needs rigorous evaluation to ensure the diagnostic validity of inhalant use disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19632058      PMCID: PMC2787661          DOI: 10.1016/j.mehy.2009.06.036

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  22 in total

1.  Inhalant use and delinquent behavior among adolescents: a comparison of inhalant users and other drug users.

Authors:  M E Mackesy-Amiti; M Fendrich
Journal:  Addiction       Date:  1999-04       Impact factor: 6.526

2.  Inhalant abuse and dependence among adolescents in the United States.

Authors:  Li-Tzy Wu; Daniel J Pilowsky; William E Schlenger
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-10       Impact factor: 8.829

3.  Sudden death after isobutane sniffing: a report of two forensic cases.

Authors:  H Pfeiffer; M Al Khaddam; B Brinkmann; H Köhler; J Beike
Journal:  Int J Legal Med       Date:  2005-12-21       Impact factor: 2.686

4.  Treatment of inhalant dependence with lamotrigine.

Authors:  Yu-Chih Shen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-12-29       Impact factor: 5.067

5.  Phenomenology of intoxication with toluene-based adhesives and butane gas.

Authors:  A C Evans; D Raistrick
Journal:  Br J Psychiatry       Date:  1987-06       Impact factor: 9.319

6.  Reliability of use, abuse, and dependence of four types of inhalants in adolescents and young adults.

Authors:  Ty A Ridenour; Bethany C Bray; Linda B Cottler
Journal:  Drug Alcohol Depend       Date:  2007-06-18       Impact factor: 4.492

Review 7.  Neural basis of inhalant abuse.

Authors:  R L Balster
Journal:  Drug Alcohol Depend       Date:  1998 Jun-Jul       Impact factor: 4.492

8.  White matter changes caused by chronic solvent abuse.

Authors:  N Yamanouchi; S Okada; K Kodama; S Hirai; H Sekine; A Murakami; N Komatsu; T Sakamoto; T Sato
Journal:  AJNR Am J Neuroradiol       Date:  1995-09       Impact factor: 3.825

9.  Neurologic sequelae of chronic solvent vapor abuse.

Authors:  J T Hormes; C M Filley; N L Rosenberg
Journal:  Neurology       Date:  1986-05       Impact factor: 9.910

10.  Baclofen in the management of inhalant withdrawal: a case series.

Authors:  Kesavan Muralidharan; Ravi Philip Rajkumar; Uzma Mulla; Raghavendra Bheemappa Nayak; Vivek Benegal
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008
View more
  6 in total

1.  Item response theory analysis of DSM-IV criteria for inhalant-use disorders in adolescents.

Authors:  Brian E Perron; Michael G Vaughn; Matthew O Howard; Amy Bohnert; Erick Guerrero
Journal:  J Stud Alcohol Drugs       Date:  2010-07       Impact factor: 2.582

2.  Service use and treatment barriers among inhalant users.

Authors:  Brian E Perron; Orion Mowbray; Sarah Bier; Michael G Vaughn; Amy Krentzman; Matthew O Howard
Journal:  J Psychoactive Drugs       Date:  2011 Jan-Mar

Review 3.  Volatile substance misuse : clinical considerations, neuropsychopharmacology and potential role of pharmacotherapy in management.

Authors:  Eric L Garland; Matthew O Howard
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

Review 4.  Volatile substance misuse: an updated review of toxicity and treatment.

Authors:  Jonathan B Ford; Mark E Sutter; Kelly P Owen; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

Review 5.  Inhalant use and inhalant use disorders in the United States.

Authors:  Matthew O Howard; Scott E Bowen; Eric L Garland; Brian E Perron; Michael G Vaughn
Journal:  Addict Sci Clin Pract       Date:  2011-07

6.  The prevalence and clinical significance of inhalant withdrawal symptoms among a national sample.

Authors:  Brian E Perron; Joseph E Glass; Brian K Ahmedani; Michael G Vaughn; Daniel E Roberts; Li-Tzy Wu
Journal:  Subst Abuse Rehabil       Date:  2011-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.